Coffee Medical Group LLC

Coffee Medical Group LLC was paid $3.62M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 33% of everything it billed.

33Billing provider infoCOFFEE MEDICAL GROUP LLC
MANCHESTER, TN 37355

33aNPI1013969179assigned 05/17/2006

33bProvider typeRural Acute Care Hospital

28Total paid$3.62M

24GClaims122,228

24DCodes billed78

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Rural Acute Care Hospital providers in Tennessee

Rank by total paid#4 of 7

Median peer was paid$3.62M

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	14,529	$382K
2019	20,311	$456K
2020	17,387	$443K
2021	21,187	$604K
2022	20,533	$686K
2023	18,238	$646K
2024incomplete	10,043	$402K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	33%	40,678	30,708	$1.21M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	31%	11,695	10,980	$1.13M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	2,757	2,502	$388K
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.4%	3,290	3,111	$231K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.9%	1,861	1,745	$215K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	4.8%	671	597	$173K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	12,063	10,758	$33K
71045	Radiologic examination, chest; single view	<1%	1,663	1,478	$21K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	452	407	$18K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	762	704	$18K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	462	410	$16K
43450		<1%	144	130	$16K

66 more codes

93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	120	$16K
80053	Comprehensive metabolic panel	<1%	8,506	$14K
36415	Collection of venous blood by venipuncture	<1%	13,949	$11K
96375	Therapeutic injection; each additional sequential IV push	<1%	897	$10K
71046	Radiologic examination, chest; 2 views	<1%	785	$9K
84484		<1%	1,393	$8K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	41	$7K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	78	$6K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,037	$6K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	30	$5K
80074		<1%	270	$5K
87279		<1%	1,868	$5K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	2,644	$5K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	340	$4K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	95	$4K
93017		<1%	209	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	306	$3K
99232	Hospital visit by a doctor, follow-up day	<1%	98	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	318	$2K
87430		<1%	453	$2K
99223	Prolong inpt eval add15 m	<1%	46	$2K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	25	$1K
94762		<1%	71	$1K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	54	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,178	$1K
80048	Basic metabolic panel (calcium, ionized)	<1%	636	$985.49
86780		<1%	169	$810.56
72100		<1%	14	$744.62
G0378	Hospital observation service, per hour	<1%	14	$670.45
83880		<1%	152	$610.46
87522	Neg quan hep c or qual rna	<1%	36	$542.12
83690		<1%	209	$534.99
82550		<1%	272	$521.22
96361	Intravenous infusion, hydration; each additional hour	<1%	40	$328.34
82150		<1%	117	$310.18
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	66	$293.08
72110		<1%	20	$261.20
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	24	$226.14
83605		<1%	52	$182.15
76000		<1%	14	$181.75
86592		<1%	95	$174.67
81003		<1%	795	$172.14
81025		<1%	106	$152.85
77002		<1%	184	$133.26
83735		<1%	130	$118.23
94375		<1%	15	$96.90
81001		<1%	386	$91.26
J2785	Injection, regadenoson, 0.1 mg	<1%	12	$85.78
94760		<1%	65	$42.56
85730		<1%	13	$28.61
85610		<1%	26	$27.14
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,589	$24.48
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,045	$15.07
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	593	$9.33
82553		<1%	12	$7.51
J0690	Injection, cefazolin sodium, 500 mg	<1%	193	$3.92
J7120	Ringers lactate infusion, up to 1000 cc	0%	2,101	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	43	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	117	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	167	$0.00
88312		0%	12	$0.00
J1885	Injection, ketorolac tromethamine, per 15 mg	0%	44	$0.00
88305	Level IV - Surgical pathology, gross and microscopic examination	0%	196	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	117	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	14	$0.00
J2704	Injection, propofol, 10 mg	0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCORMICK, MARTHA (CEO)